Evidence map›Paper›PMID 30522461›Full record

ArticleBMC urology2018

Early post-operative serum albumin level predicts survival after curative nephrectomy for kidney cancer: a retrospective study.

Yongquan Tang, Zhihong Liu, Jiayu Liang, Ruochen Zhang, Kan Wu, Zijun Zou, Chuan Zhou, Fuxun Zhang, Yiping Lu

Abstract read
In one paragraph

Article in BMC urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Serum Albumin Kinetics in Major Ovarian, Gastrointestinal, and Cervico Facial Cancer Surgery.International journal of environmental research and public health · 2022
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yongquan TangDepartment of Pediatric Surgery, West China Hospital, Sichuan University, No. 37 of Guoxue Xiang, Chengdu, 610041, China.
Zhihong LiuDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Jiayu LiangDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Ruochen ZhangDepartment of Urology, Fujian Provincial Hospital, Fuzhou, China.
Kan WuDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Zijun ZouDepartment of Urology, the Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Chuan ZhouDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Fuxun ZhangDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Yiping LuDepartment of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China. yiping_luuro@163.com.ORCID http://orcid.org/0000-0003-3555-2764

Funding

Department of Science and Technology of Sichuan Province 2014JY0183Department of Science and Technology of Sichuan Province Grant No. 2017SZ0123
6 · The paper itself

Abstract

backgroundPrevious studies have shown that albumin-related systemic inflammation is associated with the long-term prognosis of cancer, but the clinical significance of an early (≤ 7 days) post-operative serum albumin level has not been well-documented as a prognostic factor in patients with renal cell cancer.

methodsWe retrospectively included patients hospitalized for kidney cancer from January 2009 to May 2014. First, the receiver operating characteristic analysis was used to define the best cut-off of an early post-operative serum albumin level in determining the prognosis, from which survival analysis was performed.

resultsA total of 329 patients were included. The median duration of follow-up was 54.8 months. Patients with an early post-operative serum albumin level < 32 g/L had a significantly shorter median recurrence-free survival (RFS; 49.1 versus 56.5 months, P = 0.001) and median overall survival (OS; 52.2 versus 57.0 months, P = 0.049) than patients with an early post-operative serum albumin level ≥ 32 g/L. After adjusting for age, BMI, tumor stage, post-operative hemoglobin concentration, and pre-operative albumin, globulin, and hemoglobin levels, multivariate Cox regression showed that an early post-operative serum albumin level < 32 g/L was an independent prognostic factor associated with a decreased RFS (HR = 3.60; 95% CI,1.05-12.42 [months], P = 0.042) and decreased OS (HR = 9.95; 95% CI, 1.81-54.80 [months], P = 0.008).

conclusionAn early post-operative serum albumin level < 32 g/L is an independent prognostic factor leading to an unfavorable RFS and OS. Prospective trials and further studies involving additional patients are warranted.

Indexed as

AdultAgedAged, 80 and overBiomarkers, TumorFemaleHumansKidney NeoplasmsMaleMiddle AgedNephrectomyPostoperative CarePredictive Value of TestsRetrospective StudiesSerum Albumin, HumanSurvival RateYoung AdultBiomarkers, TumorSerum Albumin, HumanHypoalbuminemiaKidney cancerRadical resectionSurvival

Identifiers

PMID30522461
PMCPMC6282248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.